These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 22799366)
1. Clinical outcomes of downregulation of E-cadherin gene expression in non-small cell lung cancer. Zheng SY; Hou JY; Zhao J; Jiang D; Ge JF; Chen S Asian Pac J Cancer Prev; 2012; 13(4):1557-61. PubMed ID: 22799366 [TBL] [Abstract][Full Text] [Related]
2. Infrequently methylated event at sites -181 to -9 within the 5' CpG island of E-cadherin in non-small cell lung cancer. Liu RY; Lei Z; Li W; Xu L; Liu Z; Chen XF; Zhao J; Zhang HT Exp Lung Res; 2009 Sep; 35(7):541-53. PubMed ID: 19842844 [TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features. Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794 [TBL] [Abstract][Full Text] [Related]
4. Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer. Zhang HT; Chen XF; Wang MH; Wang JC; Qi QY; Zhang RM; Xu WQ; Fei QY; Wang F; Cheng QQ; Chen F; Zhu CS; Tao SH; Luo Z Clin Cancer Res; 2004 Apr; 10(7):2359-67. PubMed ID: 15073112 [TBL] [Abstract][Full Text] [Related]
5. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer. Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719 [TBL] [Abstract][Full Text] [Related]
6. Methylated +322-327 CpG site decreases hOGG1 mRNA expression in non-small cell lung cancer. Zeng Y; Zhu J; Qin H; Shen D; Lei Z; Li W; Ding Z; Huang JA; Liu Z Oncol Rep; 2017 Jul; 38(1):529-537. PubMed ID: 28586012 [TBL] [Abstract][Full Text] [Related]
7. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray. Wang Y; Zhang D; Zheng W; Luo J; Bai Y; Lu Z Cancer; 2008 Mar; 112(6):1325-36. PubMed ID: 18286531 [TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of E-cadherin gene is frequent and independent of p16INK4A methylation in non-small cell lung cancer: potential prognostic implication. Shimamoto T; Ohyashiki JH; Hirano T; Kato H; Ohyashiki K Oncol Rep; 2004 Aug; 12(2):389-95. PubMed ID: 15254707 [TBL] [Abstract][Full Text] [Related]
9. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma. Kao RH; Huang LC; Hsu YH Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040 [TBL] [Abstract][Full Text] [Related]
10. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170 [TBL] [Abstract][Full Text] [Related]
11. Expression of connexin 43 and E-cadherin protein and mRNA in non-small cell lung cancers in Chinese patients. Zhao JQ; Sun FJ; Liu SS; Yang J; Wu YQ; Li GS; Chen QY; Wang JX Asian Pac J Cancer Prev; 2013; 14(2):639-43. PubMed ID: 23621211 [TBL] [Abstract][Full Text] [Related]
12. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma]. Zhou YN; Xu CP; Han B; Ji R Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136 [TBL] [Abstract][Full Text] [Related]
13. [Detection of gene promoter methylation and mRNA, protein expression levels of E-cadherin in nasopharyngeal carcinoma]. Li Z; Lin SX; Liang YJ Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):25-30. PubMed ID: 12760799 [TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma. Kim JS; Han J; Shim YM; Park J; Kim DH Cancer; 2005 Nov; 104(9):1825-33. PubMed ID: 16177988 [TBL] [Abstract][Full Text] [Related]
15. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090 [TBL] [Abstract][Full Text] [Related]
16. The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma. Yeh KT; Shih MC; Lin TH; Chen JC; Chang JY; Kao CF; Lin KL; Chang JG Anticancer Res; 2002; 22(6C):3971-5. PubMed ID: 12553020 [TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310 [TBL] [Abstract][Full Text] [Related]
19. Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers. Imoto I; Izumi H; Yokoi S; Hosoda H; Shibata T; Hosoda F; Ohki M; Hirohashi S; Inazawa J Cancer Res; 2006 May; 66(9):4617-26. PubMed ID: 16651412 [TBL] [Abstract][Full Text] [Related]
20. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Zöchbauer-Müller S; Fong KM; Maitra A; Lam S; Geradts J; Ashfaq R; Virmani AK; Milchgrub S; Gazdar AF; Minna JD Cancer Res; 2001 May; 61(9):3581-5. PubMed ID: 11325823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]